Novo Nordisk AS (NVO)
104.54
-0.52
(-0.49%)
USD |
NYSE |
Nov 25, 16:00
104.56
+0.02
(+0.02%)
After-Hours: 20:00
Novo Nordisk Total Return Level: 183.50 for Nov. 22, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 22, 2024 | 183.50 |
November 21, 2024 | 179.25 |
November 20, 2024 | 183.86 |
November 19, 2024 | 179.25 |
November 18, 2024 | 174.33 |
November 15, 2024 | 177.70 |
November 14, 2024 | 183.95 |
November 13, 2024 | 186.73 |
November 12, 2024 | 186.99 |
November 11, 2024 | 190.54 |
November 08, 2024 | 187.24 |
November 07, 2024 | 187.99 |
November 06, 2024 | 184.02 |
November 05, 2024 | 192.35 |
November 04, 2024 | 191.64 |
November 01, 2024 | 195.51 |
October 31, 2024 | 195.53 |
October 30, 2024 | 197.79 |
October 29, 2024 | 195.58 |
October 28, 2024 | 196.25 |
October 25, 2024 | 198.03 |
October 24, 2024 | 198.97 |
October 23, 2024 | 202.15 |
October 22, 2024 | 203.43 |
October 21, 2024 | 204.93 |
Date | Value |
---|---|
October 18, 2024 | 206.26 |
October 17, 2024 | 206.48 |
October 16, 2024 | 206.15 |
October 15, 2024 | 205.77 |
October 14, 2024 | 209.21 |
October 11, 2024 | 209.66 |
October 10, 2024 | 205.28 |
October 09, 2024 | 204.35 |
October 08, 2024 | 204.70 |
October 07, 2024 | 205.70 |
October 04, 2024 | 201.07 |
October 03, 2024 | 201.00 |
October 02, 2024 | 203.44 |
October 01, 2024 | 206.12 |
September 30, 2024 | 207.97 |
September 27, 2024 | 210.92 |
September 26, 2024 | 217.10 |
September 25, 2024 | 221.73 |
September 24, 2024 | 219.09 |
September 23, 2024 | 216.05 |
September 20, 2024 | 222.71 |
September 19, 2024 | 235.58 |
September 18, 2024 | 230.66 |
September 17, 2024 | 230.55 |
September 16, 2024 | 239.11 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
39.92
Minimum
Mar 20 2020
255.61
Maximum
Jun 25 2024
113.50
Average
91.91
Median
Mar 23 2022
Total Return Level Benchmarks
Ascendis Pharma AS | 129.81 |
Amgen Inc | 418.63 |
AstraZeneca PLC | 396.90 |
Viking Therapeutics Inc | 52.59 |
Evaxion Biotech AS | 1.49 |